Supplementary Table 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
Dongwei Li(Snap (United States)), Andrew G. Polson(Sunesis (United States)), Kirsten Achilles Poon, Franklin Fuh, Saileta Prabhu, David Dornan, Jacqueline McBride, Vanitha Ramakrishnan, Rong Deng(Sun Yat-sen University), Kristi Elkins, Dimitry M. Danilenko, Denise Nazzal, Katherine R. Kozak(University of California, Los Angeles), Andrew Jack(University of Alberta), Allen Ebens(Unknown), Ruth de Tute(Leeds Teaching Hospitals NHS Trust), Randall Dere, Josefa Chuh, Xiaoyan Shi, William Ho(Baker Heart and Diabetes Institute), Yu‐Waye Chu, Marna Williams(Stanford University), Pamela Chan, Bing Zheng, MaryAnn Go, Andy C. Rawstron(University of Leeds), Jeffrey Lau, Shang‐Fan Yu(Genesys (United States))
Cited by 0
Related Papers
Multi-criteria decision making approaches for supplier evaluation and selection: A literature review
|European Journal of Operational Research|2009|2.2k
Supply chain risk management: a literature review
|International Journal of Production Research|2015|1.3k
Integrated analytic hierarchy process and its applications – A literature review
|European Journal of Operational Research|2007|1.2k
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
|Nature Biotechnology|2012|997